Humana offers LabCorp at-home COVID-19 test, partners with Walmart, Quest

LabPulse.com staff writers
Jun 29, 2020
2020 04 22 18 18 5522 Coronavirus Cells Lungs 400

Health insurer Humana is offering LabCorp's at-home COVID-19 test kit in a pilot home testing program for members. It has also formed a new collaboration with Walmart and Quest Diagnostics to provide drive-through testing for Humana members at Walmart Neighborhood Market drive-through locations.

Those seeking an at-home kit can order it via LabCorp's Pixel by LabCorp online platform.

Humana members with Medicare Advantage, Medicare supplemental insurance, Medicaid, or employer group plans are eligible for the tests. The company said it will waive member costs.

Latest in Infectious
Ticks Sign Social
AI-guided rapid Lyme disease test shows promise for early detection
August 29, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Monkeypox Virus Social
Seegene develops two RUO mpox assays
August 26, 2024
Sepsis Bacteria Social
BioMérieux receives 510(k) certification for antimicrobial testing system
August 21, 2024
Related Stories
Telemedicine Patient Doctor2 Social
Point-of-Care Testing
Simple Healthkit at-home testing kits on Walmart.com
3d Closeup Coronavirus Social
Financial Results
Labcorp Q4 revenues drop 10% despite base business growth
2019 04 24 17 43 1766 Hands Shaking2 400
Infectious
Walmart, UnitedHealth collaborate on affordable health services
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Infectious
AI-guided rapid Lyme disease test shows promise for early detection
By LabPulse.com staff writers
A new test under development that uses artificial intelligence (AI) and a format similar to that of at-home COVID-19 tests has been shown to accurately identify Lyme disease within 20 minutes.
August 29, 2024
Ticks Sign Social
CDC prioritizes mpox specimens for testing laboratories
By LabPulse.com staff writers
The CDC recommended that all laboratories performing mpox testing send certain types of clinical specimens to a laboratory that can perform clade-specific testing as quickly as possible.
August 28, 2024
Monkeypox Virus Social
Seegene develops two RUO mpox assays
By LabPulse.com staff writers
Seegene has developed two polymerase chain reaction (PCR) test assays for mpox research testing.
August 26, 2024
Monkeypox Virus Social
BioMérieux receives 510(k) certification for antimicrobial testing system
By LabPulse.com staff writers
BioMérieux has received 510(k) clearance from the U.S. Food and Drug Administration for its Vitek Reveal AST system, which reports antimicrobial susceptibility testing (AST) results directly from positive blood cultures.
August 21, 2024
Sepsis Bacteria Social
Roche announces support for mpox response
By LabPulse.com staff writers
Roche is supporting the response to the global mpox health emergency by providing increased access to polymerase chain reaction (PCR) testing and partnering with governments, healthcare providers, and organizations to combat the mpox outbreak.
August 21, 2024
Monkeypox Virus Social
CDC, WHO update on mpox outbreak
By LabPulse.com staff writers
The Centers for Disease Control and Prevention (CDC) recommended clinicians and jurisdictions in the U.S. maintain a heightened index of suspicion for monkeypox (mpox).
August 14, 2024
CDC mpox data, cases reported to the CDC as of August 1, 2024. (Source: U.S. CDC)
Accelerate Diagnostics completes preclinical trial for antimicrobial test system
By LabPulse.com staff writers
Accelerate Diagnostics successfully completed the preclinical trial of its WAVE antimicrobial susceptibility testing system.
August 12, 2024
Bacteria Blood Sepsis Social
Siga Technologies, HHS sign $113M procurement deal for smallpox, mpox treatment
By LabPulse.com staff writers
Biotech company Siga Technologies announced that the U.S. Department of Health and Human Services (HHS) exercised a procurement option on an existing contract with Siga to deliver approximately $113 million of the firm's oral antiviral treatment TPoxx.
July 22, 2024
3 D Monkeypox Infecting Cell Social
Alveo develops rapid test for avian flu
By LabPulse.com staff writers
Diagnostics firm Alveo Technologies has developed a rapid, point-of-need diagnostic for avian influenza that can detect the H5N1 variant based on sequences published from recent human and cattle infections.
July 23, 2024
Lab Virus Bacteria Research Social
Diasorin C. auris test gets FDA de novo authorization
By LabPulse.com staff writers
Diasorin has received de novo authorization from the U.S. Food and Drug Administration (FDA) for its test kit for Candida auris, a multidrug-resistant fungal pathogen common in healthcare settings.
July 16, 2024
Candida 3 D Social
Tiba Biotech awarded BARDA contract for influenza therapeutics
By LabPulse.com staff writers
Tiba Biotech has been awarded an Easy Broad Agency Announcement R&D contract through the Biomedical Advanced Research and Development Authority (BARDA) to develop therapeutics against influenza.
July 12, 2024
Influenza Virus Social
New assay developed for persistent African HIV strains
By LabPulse.com staff writers
A multinational research team has developed a test to measure the persistence of HIV in people who have been infected by strains of the virus found predominantly in Africa, providing a necessary tool in the search for a cure for HIV.
July 9, 2024
Hiv Virions Cdc Social
Page 1 of 151
Next Page